Wnt-targeted hair loss treatment
Scope
Date
~
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals introduces Tiglutik, treatment for Lou Gehrig's disease
SK Chemicals said on Monday that it is strengthening its portfolio of neurological diseases by introducing Tiglutik (riluzole), Lou Gehrig's disease...
Jan 02, 2023 (Gmt+09:00)
-
Pension funds
Korea’s NPS to be in red in 2022 with 5.3% loss in Jan-Oct
South Korea’s National Pension Service (NPS), the world’s third-largest such fund, is poised to report an annual loss in 2022 for the fi...
Jan 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Korean biotechs target US labs to speed up regulatory approval for tests
South Korean molecular diagnostics companies are increasingly buying high-quality laboratories in the US that meet federal regulatory standards in a...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CENYX Biotech, developing treatment for brain damage with ROS-scavenging, nano-sized heavy metals
When severe brain diseases such as cerebral infarction or cerebral hemorrhage occur, the blood-brain barrier (BBB) in our body no longer functions p...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Electronics
LG Innotek to unveil precision smartphone camera module
South Korea's LG Innotek said on Thursday it will unveil its high-magnification optical camera module with continuous zoom next month at CES 2023, t...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
ToolGen, ANLBIO to jointly develop progeria treatments
South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...
Dec 21, 2022 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Systems to build network to share land, sea, air target info
South Korea's Hanwha Systems Co. will start domestic research and development of new tactical data links used by member countries of the North Atlan...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
Seegene's COVID-19 diagnostic product wins Product of the Year Award
Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...
Dec 16, 2022 (Gmt+09:00)
-
Corporate strategy
Samsung eyes new mobile AP chip to take on Apple's iPhone
Samsung Electronics Co. and Apple Inc. have had a long rivalry in the global market for smartphones and other mobile devices. In terms of sales...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem in $95.5 million drug out-licensing deal with China’s Innovent
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Korean food
Sulbing opens 1st US store in California in March next year
South Korean dessert café Sulbing said on Friday that it signed a new master franchise contract to declare its entry into the US market and a...
Dec 09, 2022 (Gmt+09:00)
-
Travel & Leisure
Lordsystem, NHN Doctortour agree to promote mobile passport authentication service
South Korea’s two companies, Lordsystem and NHN Doctortour, decided to cooperate on mobile passport identity verification services, which wi...
Dec 09, 2022 (Gmt+09:00)
-
Leadership & Management
Samsung tightens belt to gird for worsening economic conditions
Samsung Electronics Co., the world’s largest memory chip and smartphone maker, is drastically cutting costs while maintaining investments in f...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals launches epilepsy drug in France
South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...
Dec 09, 2022 (Gmt+09:00)
-
Beauty & Cosmetics
Shinsegae Int'l secures domestic sales rights for Italian brand Davines
South Korea's fashion retail giant Shinsegae International on Monday said it has acquired the domestic rights to sell the Italian haircare brand Dav...
Dec 06, 2022 (Gmt+09:00)
-
Shipping & Shipbuilding
Korean shipbuilder KSOE wins $308 million order for 2 ethane carriers
Korea Shipbuilding & Offshore Engineering (KSOE), the holding company of the world’s top shipbuilder Hyundai Heavy Industries Group, said ...
Dec 02, 2022 (Gmt+09:00)
-
Supply chain
Korea’s industrial losses balloon to $1.2 bn as truckers continue strike
South Korea’s manufacturing sector faces ballooning losses across industries as the trucker strike entered its eighth day on Thursday, disrupt...
Dec 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion to enter dental disease treatment sector
Orion Corp., the Korean company, best known for its signature product choco pie, is entering drug development. Instead of indirectly running a joint...
Nov 30, 2022 (Gmt+09:00)
-
Pension funds
NPS posts 7% investment loss in Q1-Q3 as equities, bonds plunge
National Pension Service (NPS) of South Korea said Tuesday it saw a cumulative loss of 7.1% on investment, or 68 trillion won ($51.3 billion), betwe...
Nov 29, 2022 (Gmt+09:00)
-
Korean startups
Sandbox Network pursues corporate restructuring to dig out of red
Sandbox Network, Inc. announced on Sunday that it will go through corporate restructuring and encourage employees to voluntarily resign, hit by cont...
Nov 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Waste management
BKT thrives as lone Korean wastewater treatment provider in US
South Korean water treatment provider Bukang Tech(BKT) on Wednesday said it earned a contract to build a wastewater treatment facility in the US sta...
Nov 18, 2022 (Gmt+09:00)
-
Foreign exchange
Korean exporters suffer FX derivate losses on weak won
More South Korean exporters suffered massive losses from foreign exchange derivatives on a weaker won, failing to benefit from the unit’s depr...
Nov 17, 2022 (Gmt+09:00)
Latest News
- 1 Invesco, SK D&D likely to buy co-living building in Seoul
- 2 Coupang bids for Korean luxury market dominance with Farfetch
- 3 Hyundai Rotem set to finalize $6 bn K2 tank order from Poland
- 4 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 5 Korea to allow non-profits to buy bad consumer loans